Filgotinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adults who have responded inadequately to, or who are intolerant to one or more diseaseâmodifying antiârheumatic drugs (DMARDs). Filgotinib may be used as monotherapy or in combination with methotrexate (MTX).